P95vav associates with the nuclear protein Ku-70

Molecular and Cellular Biology

Volumn 16, Issue 1, 1996, Pages 37-44

  Romero, Francisco ^a   Dargemont, Catherine ^b   Pozo, Françoise ^a   Reeves, Westley H ^c   Camonis, Jacques ^d   Gisselbrecht, Sylvie ^a   Fischer, Siegmund ^a  

^a Université Paris Descartes   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY DNA; DNA BINDING PROTEIN; DNA DEPENDENT PROTEIN KINASE; HYBRID PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PRIMER DNA; PRKDC PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; VAV PROTEIN; VAV1 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CELL FRACTIONATION; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN BINDING; SRC HOMOLOGY DOMAIN; CELLULAR DISTRIBUTION; DNA LIBRARY; ENZYME LOCALIZATION; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; THYMOCYTE;

BASE SEQUENCE; BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; DNA PRIMERS; DNA, COMPLEMENTARY; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POINT MUTATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS; SUBCELLULAR FRACTIONS;

EID: 0029656269     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.1.37     Document Type: Article

References (67)

1. vav in human hematopoietic cells. J. Biol. Chem. 267:18021-18025.
2. Bartel, P. L., C. T. Chien, R. Sternglanz, and S. Fields. 1993. Using the two hybrid system to detect protein-protein interactions, p. 153-179 In D. A. Hartley (ed.). Cellular interactions in development: a practical approach. Oxford University Press, Oxford
3. Benichou, S., M. Bomsel, M. Bodéus, H. Durand, M. Douté, F. Letourneur, J. Camonis, and R. Benarous. 1994. Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269:30073-30076.
4. Blier, P. R., A. J. Griffith, J. Craft, and J. A. Hardin. 1993. Binding of Ku protein to DNA. J. Biol. Chem. 268:7594-7601.
5. Boguski, M. S., and F. McCormick. 1993. Proteins regulating Ras and its relatives. Nature (London) 366:643-654.
6. Breeden, L., and K. Nasmyth. 1985 Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50:643-650.
7. Bustelo, X. R., and M. Barbacid. 1992. Tyrosine phosphorylalion of the vav proto-oncogene product in activated B cells. Science 256:1196-1199.
8. Bustelo, X. R., J. A. Ledbetter, and M. Barbacid. 1992. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature (London) 356:68-71.
9. Bustelo, X. R., K. L. Suen, K. Leftheris, C. A. Meyers, and M. Barhacid. 1994. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9:2405-2413.
10. Bustelo, X. R., K. L. Suen, W. M. Michael, G. Dreyfuss, and M. Barbacid. 1995 Association of vav proto-oncogene product with poly(rC)-specific RNA-binding proteins Mol. Cell. Biol 15:1324-1332.
11. Camonis, J. Unpublished data.
12. Clark, S. G., M. J. Stern, and H. R. Horvitz. 1992. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature (London) 356:340-344.
13. Clevenger, C. V., W. Ngo, D. L. Sokol, S. M. Luger, and A. M. Gewirtz. 1995. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line J. Biol. Chem. 270:13246-13253
14. Coppula, J., S. Bryant, T. Koda, D. Conway, and M. Barbacid. 1991. Mechanism of activation of the vav protooncoaene. Cell Growth Differ. 2:95-105.
15. de Vries, E., W. V. van Driel, W. G. Bergsma, A. C. Arnberg, and P. C. van der Vliet. 1989. HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex. J. Mol. Biol 208:65-78.
16. Dosil, M., S. Wang, and I. R. Lemischka. 1993. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin-3-dependent hematopoietic cells Mol. Cell. Biol. 13:6572-6585.
17. Dusanter-Fourt, I., N. Casadevall, C. Lacombe, O. Muller, C. Billat, S. Fischer, and P. Mayeux. 1992. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J. Biol. Chem. 267:10670-10675.
18. Dvir, A., L. Y. Stein, B. L. Calore, and W. S. Dynan. 1993. Purification and characterization of a template-associated protein kinase that phosphorylates RNA polymerase II. J Biol. Chem. 268:10440-10447.
19. Eck, M. J., S. K. Atwell, S. E. Shoelson, and S. C. Harrison. 1994 Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature (London) 368:764-769
20. Evans, G. A., O. M. Z. Howard, R. Erwin, and W. L. Farrar. 1993. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells lack of requirement for tyrosine kinase lck. Biochem. J. 294: 339-342.
21. Falzon, M., J. W. Fewell, and E. L. Kuff. 1993 EPB-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. J. Biol. Chem. 268:10546-10552
22. Feldman, H., and E. L. Winnacker. 1993. A putative homologue of the human autoantigen Ku from Saccharomyces cerevisiae. J Biol. Chem 268: 12895-12900.
23. Fields, S., and O. K. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature (London) 340:245-246.
24. + thymocytes. Nature (London) 374:474-476.
25. Francoeur, A. M., C. L. Peebles, P. T. Gompper, and E. M. Tan. 1986. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity J. Immunol. 136:1648-1653
26. Getts, R. C., and T. D. Stamato. 1994 Absence of a Ku-like DNA end-binding activity in the xrs double-strand DNA repair deficient mutant J. Biol. Chem. 269:15981-15984.
27. Griffith, A. J., P. R. Blier, T. Mimori, and J. A. Hardin. 1992. Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA J Biol Chem. 267:331-338.
28. Gulbins, E., K. M. Coggeshall, G. Baier, S. Katzav, P. Burn, and A. Altman. 1993 Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 260:822-825
29. Gulbins, E., K. M. Coggeshall, G. Baier, D. Telford, C. Langlet, G. Baier-Bitterlich, N. Bonnefoy-Berard, P. Burn, A. Wittinghofer, and A. Altman. 1994. Direct stimulation of Vav guanine nucleotide exchanges activity for Ras by phorbol esters and diglycerides Mol. Cell. Biol. 14:4749-4758.
30. Gulbins, E., K. M. Coggeshall, C. Langlet, G. Baier, N. Bonnefoy-Berard, P. Burn, A. Wittinghofer, S. Katzav, and A. Altman. 1994 Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol. Cell Biol. 14:906-913.
31. Gulbins, E., C. Langlet, G. Baier, N. Bonnefoy-Berard, E. Herbert, A. Altman, and K. M. Coggeshall. 1994. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. J. Immunol. 94:2123-2129
32. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391.
33. Higashiura, M., Y. Shimizu, M. Tanimoto, T. Morita, and T. Yagura. 1992. Immunolocalization of Ku-proteins (p70/p80): localization of p70 to the nucleoli and periphery of both interphase nuclei and metaphase chromosomes. Exp. Cell Res. 201:444-451
34. vav/heterogeneous ribonuclcoprotein K interaction. J. Biol. Chem. 269:20225-20228.
35. Hu, P., B. Margolis, and J. Schlessinger. 1993 Vav: a potential link between tyrosine kinases and Kas-like GTPases in hematopoietic cell signaling. Bioessays 15:179-183.
36. Katzav, S., J. L. Cleveland, H. E. Heslop, and D. Pulido. 1991 Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell. Biol. 11:1912-1920.
37. Katzav, S., D. Martin-Zanca, and M. Barbacid. 1989. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283-2290.
38. Katzas, S., M. Sutherland, G. Packham, T. Yi, and A. Weiss. 1994. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J. Biol. Chem 269:32579-32585.
39. Khosravi-Far, R., M. Chrzanowska-Wodnicka, P. A. Solski, A. Eva, K. Burridge, and C. J. Der. 1994. Vav and Dbl mediate transformation via Ras-independent mitogen-activated protein kinase activation. Mol Cell. Biol. 14: 6848-6857.
40. Knuth, M. W., S. I. Gunderson, N. E. Thompson, L. A. Strasheim, and R. R. Burgess. 1990. Purification and characterization of proximal sequence element-binding protein 1, a transcription activating protein related to Ku and TREF that binds the proximal sequence element of the human U1 promoter. J. Biol. Chem. 265:17911-17920.
41. Kuhn, A., T. M. Gottlieb, S. P. Jackson, and I. Grummt. 1995. DNA-dependent protein kinase: a potent inhibitor of transcription by RNA polymerase 1. Genes Dev. 9:193-203
42. Lees-Miller, S. P., Y. R. Chen, and C. W. Anderson. 1990 Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell Biol. 10: 6472-6481.
43. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-142.
44. Margolis, B., P. Hu, S. Katzai, W. Li, J. M. Oliver, A. Clinch, A. Weiss, and J. Schlessinger. 1992 Tyrosine phosphorylatiou of vav proto-oncogene product containing SH2 domain and transcription factor motifs Nature (London) 356:71-74.
45. Mimori, T., M. Akizuki, H. Yamagata, S. Inada, S. Yoshida, and M. Homma. 1981 Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies from patients with polymyositis-scleroderma overlap J Clin. Invest. 68:611-620.
46. Miura, O., Y. Miura, N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki. 1994. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 12:4135-4141
47. Musacchio, A., T. Gibson, P. Rice, J. Thompson, and M. Saraste. 1993. The PH domain, a common piece in the structural patchwork of signaling proteins. Trends Biochem. Sci. 18:343-348.
48. 1BF from serum-deprived cells Proc Natl. Acad. Sci. USA 91:9101-9105
49. Pallard, C., F. Gouilleux, L. Bénit, L. Cocault, M. Souyri, D. Levy, B. Groner, S. Gisselbrecht, and I. Dusanter-Fourt. 1995 Thiombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J. 14:2847-2856.
50. Platanias, L. C., and M. E. Sweet. 1994. Interferon α induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells J. Biol. Chem 269:3143-3146.
51. Puil, L., and T. Pawson. 1992 Vagaries of Vav. Curr. Biol 2:275-277
52. Ramos-Morales, F., B. J. Druker, and S. Fischer. 1994. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes Oncogene 9:1917-1923.
53. Ramos-Morales, F., F. Romero, F. Schweighoffer, G. Bismuth, J. Camonis, M. Tortolero, and S. Fischer. 1995. The proline-rich region of Vav binds to Grb2 and Grb3-3. Oncogene 11:1665-1669.
54. Reeves, W. H. 1985. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera J. Exp. Med. 161:18-39
55. Reeves, W. H., M. Satoh, J. Wang, and A. K. Ajmani. 1994. Ku and related antigens, p. 1-22. In W. J. van Venrooij and R. N. Maini (ed.). Manual of biological markers of disease. Kluwer Academic Publishers. Dordrecht, The Netherlands.
56. Roberts, M. R., W. K. Miskimins, and F. H. Ruddle. 1989. Nuclear proteins TREF1 and TREF2 bind to the transcriptional control element of the transferrin receptor gene and appear to be associated as a heterodimer. Cell Regul. 1:151-164.
57. Sanger, F., S. Nieklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad Sci. USA 74:5463-5467.
58. Sherman, F., G. R. Fink, and J. B. Hicks. 1986. Methods in yeast genetics. Cold Spring Harhor Laboratory. Cold Spring Harbor, N Y.
59. Stuiver, M. H., F. E. J. Coenjaerts, and P. C. van der Vliet. 1990. The autoantigen Ku is indistinguishable from NF IV, a protein forming multimeric protein-DNA complexes J. Exp. Med. 172:1049-1054.
60. Taccioli, G. E., T. M. Gottlieb, T. Blunt, A. Priestly, J. Demengeot, R. Mizuta, A. R. Lehmann, F. W. Alt, S. P. Jackson, and P. A. Jeggo. 1994 Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265:1442-1445.
61. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. J. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature (London) 374: 467-470.
62. van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217.
63. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf Cell 74:205-214.
64. Yaneva, M., R. Ochs, D. K. McRorie, S. Zweig, and H. Busch. 1985 Purification of an 85-70 kDa nuclear DNA-associated protein complex. Biochim. Biophys. Acta 841:22-29
65. Ye, Z. S., and D. Baltimore. 1994. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl Acad. Sci. USA 91:12629-12633.
66. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene Nature (London) 374:470-473.
67. Zmuidzinas, A., K. D. Fischer, S. A. Lira, L. Forrester, S. Bryant, A. Bernstein, and M. Barbacid. 1995. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J. 14: 1-11.